9 May 2017
Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections, regenerative medicines, etc. Its breakthrough product is Trombovazim, a powerful thrombolytic with a very high bio-accessibility created using Axis technology, an innovative medicine that has no comparable drugs in the world’s pharma market.
The BIO International Convention is the largest global event for the biotechnology industry that attracts the leading companies in biotech, offering key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
© Oaklins, all rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.